鳥居薬品の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/09/26 | 2,728 | 2,755 | 2,726 | 2,732 | -29 | -1.1% | 30,600 |
| 2022/09/22 | 2,755 | 2,775 | 2,735 | 2,761 | -37 | -1.3% | 43,300 |
| 2022/09/21 | 2,785 | 2,804 | 2,751 | 2,798 | -13 | -0.5% | 43,200 |
| 2022/09/20 | 2,797 | 2,879 | 2,797 | 2,811 | +14 | +0.5% | 66,400 |
| 2022/09/16 | 2,781 | 2,799 | 2,760 | 2,797 | -11 | -0.4% | 42,700 |
| 2022/09/15 | 2,840 | 2,842 | 2,794 | 2,808 | -26 | -0.9% | 42,500 |
| 2022/09/14 | 2,858 | 2,871 | 2,834 | 2,834 | -59 | -2% | 38,300 |
| 2022/09/13 | 2,865 | 2,895 | 2,865 | 2,893 | +32 | +1.1% | 30,100 |
| 2022/09/12 | 2,914 | 2,916 | 2,857 | 2,861 | -44 | -1.5% | 30,600 |
| 2022/09/09 | 2,847 | 2,913 | 2,847 | 2,905 | +71 | +2.5% | 45,900 |
| 2022/09/08 | 2,810 | 2,877 | 2,810 | 2,834 | +31 | +1.1% | 78,300 |
| 2022/09/07 | 2,877 | 2,877 | 2,802 | 2,803 | -73 | -2.5% | 34,600 |
| 2022/09/06 | 2,904 | 2,922 | 2,856 | 2,876 | -30 | -1% | 59,600 |
| 2022/09/05 | 2,915 | 2,933 | 2,906 | 2,906 | -29 | -1% | 31,700 |
| 2022/09/02 | 2,991 | 2,991 | 2,922 | 2,935 | -44 | -1.5% | 61,600 |
| 2022/09/01 | 2,980 | 2,996 | 2,963 | 2,979 | -21 | -0.7% | 61,400 |
| 2022/08/31 | 2,942 | 3,000 | 2,942 | 3,000 | +19 | +0.6% | 31,300 |
| 2022/08/30 | 2,960 | 2,981 | 2,955 | 2,981 | +21 | +0.7% | 31,900 |
| 2022/08/29 | 2,961 | 2,976 | 2,953 | 2,960 | -27 | -0.9% | 32,800 |
| 2022/08/26 | 2,993 | 3,000 | 2,985 | 2,987 | -6 | -0.2% | 14,900 |
| 2022/08/25 | 3,005 | 3,015 | 2,993 | 2,993 | -5 | -0.2% | 20,500 |
| 2022/08/24 | 3,000 | 3,010 | 2,967 | 2,998 | -7 | -0.2% | 51,700 |
| 2022/08/23 | 3,050 | 3,050 | 3,005 | 3,005 | -75 | -2.4% | 20,100 |
| 2022/08/22 | 3,065 | 3,085 | 3,050 | 3,080 | +10 | +0.3% | 23,700 |
| 2022/08/19 | 3,085 | 3,100 | 3,055 | 3,070 | +10 | +0.3% | 19,300 |
| 2022/08/18 | 3,100 | 3,105 | 3,060 | 3,060 | -55 | -1.8% | 22,600 |
| 2022/08/17 | 3,110 | 3,130 | 3,095 | 3,115 | +20 | +0.6% | 19,600 |
| 2022/08/16 | 3,085 | 3,105 | 3,065 | 3,095 | +10 | +0.3% | 17,900 |
| 2022/08/15 | 3,095 | 3,110 | 3,060 | 3,085 | -10 | -0.3% | 28,400 |
| 2022/08/12 | 3,075 | 3,130 | 3,065 | 3,095 | +45 | +1.5% | 39,700 |
| 2022/08/10 | 3,060 | 3,060 | 3,025 | 3,050 | -20 | -0.7% | 18,100 |
| 2022/08/09 | 3,085 | 3,105 | 3,050 | 3,070 | -5 | -0.2% | 31,100 |
| 2022/08/08 | 3,070 | 3,080 | 3,040 | 3,075 | -5 | -0.2% | 42,400 |
| 2022/08/05 | 3,045 | 3,085 | 3,035 | 3,080 | +82 | +2.7% | 41,800 |
| 2022/08/04 | 3,040 | 3,050 | 2,994 | 2,998 | -42 | -1.4% | 32,000 |
| 2022/08/03 | 3,110 | 3,110 | 3,035 | 3,040 | -15 | -0.5% | 39,800 |
| 2022/08/02 | 3,165 | 3,190 | 3,045 | 3,055 | -95 | -3% | 73,700 |
| 2022/08/01 | 3,230 | 3,245 | 3,140 | 3,150 | -140 | -4.3% | 99,100 |
| 2022/07/29 | 3,370 | 3,395 | 3,265 | 3,290 | -60 | -1.8% | 86,100 |
| 2022/07/28 | 3,300 | 3,350 | 3,255 | 3,350 | +85 | +2.6% | 237,400 |
| 2022/07/27 | 3,300 | 3,300 | 3,255 | 3,265 | -15 | -0.5% | 35,800 |
| 2022/07/26 | 3,295 | 3,305 | 3,280 | 3,280 | -5 | -0.2% | 32,800 |
| 2022/07/25 | 3,320 | 3,330 | 3,285 | 3,285 | -45 | -1.4% | 32,000 |
| 2022/07/22 | 3,350 | 3,360 | 3,330 | 3,330 | -35 | -1% | 25,200 |
| 2022/07/21 | 3,310 | 3,375 | 3,310 | 3,365 | -5 | -0.1% | 38,900 |
| 2022/07/20 | 3,355 | 3,385 | 3,335 | 3,370 | +70 | +2.1% | 58,900 |
| 2022/07/19 | 3,300 | 3,310 | 3,240 | 3,300 | ±0 | ±0% | 62,000 |
| 2022/07/15 | 3,370 | 3,370 | 3,290 | 3,300 | -50 | -1.5% | 40,700 |
| 2022/07/14 | 3,340 | 3,360 | 3,315 | 3,350 | -15 | -0.4% | 48,300 |
| 2022/07/13 | 3,365 | 3,395 | 3,345 | 3,365 | -45 | -1.3% | 61,600 |
651～
700
件表示中 / 3705件
類似銘柄と比較する
現在ご覧いただいている「鳥居薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 鳥居薬 | 633,000円 | +7.1% | -35.0% | 0.00% | 52.34倍 | 1.46倍 |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
| ペプチド | 167,300円 | +5.0% | +1.5% | 0.00% | 14.31倍 | 3.81倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
| キッセイ薬 | 385,500円 | +3.6% | +6.1% | 3.11% | 12.99倍 | 0.76倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
| 科研薬 | 373,800円 | -6.4% | -71.8% | 5.08% | 41.63倍 | 0.93倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| 東和薬品 | 299,500円 | +7.9% | -3.3% | 2.67% | 8.33倍 | 0.86倍 |
|
後発医薬品メーカーで国内２強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
市場注目の銘柄
チャート関連のコラム
